T&L
티앤엘 · 340570
Health Care Pharmaceuticals · KOSDAQ
Market cap US$320.4M (₩442.2B)
Overview
T&L makes wound dressings, medical coverings that protect injuries, absorb fluid, and prevent contamination, along with microneedles and orthopaedic immobilisation supports such as casts and splints.
Its products are used in medical and personal-care settings, and the company is listed on KOSDAQ, South Korea's tech and small-cap exchange. Wound dressings form the core of its business, with microneedle and cosmetic products developed as extensions of the same advanced polymer materials technology.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$119M
▼ −6.1% YoY
Operating profit · FY2025
US$33.6M
▼ −18.6% YoY
Net income · FY2025
US$27.6M
▼ −18.0% YoY
Revenue
- FY2023US$83.7M
- FY2024US$126.7M
- FY2025US$119M
Operating profit
- FY2023US$22.3M
- FY2024US$41.3M
- FY2025US$33.6M
Net income
- FY2023US$19.9M
- FY2024US$33.6M
- FY2025US$27.6M
Key ratios (FY2025)
ROE
18.9%
Debt/Eq
7.9%
Op. margin
28.2%
Net margin
23.2%
Rev. YoY
▼ −6.1%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?